Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-030048
Filing Date
2014-08-25
Accepted
2014-08-25 13:49:47
Documents
1
Period of Report
2014-08-22

Document Format Files

Seq Description Document Type Size
1 rrd415080.html 4  
1 rrd415080.xml 4 10526
  Complete submission text file 0001181431-14-030048.txt   11844
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
Weller Harry R (Reporting) CIK: 0001362942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 141062201

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations